Asthma UK Scotland Comment On SMC Approval Of Xolair

Main Category: Respiratory / Asthma
Also Included In: Allergy;  Regulatory Affairs / Drug Approvals
Article Date: 10 Oct 2007 - 1:00 PDT

email to a friend   printer friendly   opinions  

Shona Haslam, National Director at Asthma UK Scotland, said:

'The approval of Xolair is not only a victory for Asthma UK Scotland but a victory for people with severe allergic asthma across Scotland. We are delighted this third review of Xolair has been successful and will ensure that these people have access to this life-changing drug on the NHS and we are continuing to campaign hard for its roll out to the rest of the UK.

'There are nearly 400,000 people in Scotland currently living with asthma, many of them able to control their condition using existing asthma drugs and have a symptom free lifestyle. However, some people with severe allergic asthma experience numerous emergency hospital admissions throughout the year and existing drugs simply do not help to control their asthma effectively.

'Xolair will radically help these people and will, literally, change their lives. It will give them the opportunity to work, go on holiday, have a night out or even just walk to the shops, without the constant fear that their next asthma attack could be fatal. This is truly a ground-breaking result for people with asthma.'

http://www.asthma.org.uk

• Additional
• References
• Citations